Contact Us

Global Short-Acting Insulin Market Overview 2025: Competitive Analysis & Growth Trends

29 Apr, 2025

The Short-Acting Insulin Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Short-Acting Insulin Market?

The global short-acting insulin market has seen substantial growth recently. The market size is projected to increase from $11.00 billion in 2024 to $11.65 billion in 2025, signifying a compound annual growth rate (CAGR) of 5.9%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Short-Acting Insulin Industry?

The Short-Acting Insulin Global Market Report 2025 predicts that by 2029, the market will expand to a size of $14.47 billion, with a compound annual growth rate (CAGR) of 5.6%.

Download Your Free Sample of the 2025 Short-Acting Insulin Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Short-Acting Insulin Market?

The key drivers in the short-acting insulin market are:

• Uptick in governmental initiatives and support for insulin therapy
• Rapid innovations in the production of short-acting insulin
• Increasing global adoption of insulin therapy and personalized medicine
• Advancements in insulin delivery devices and technologies, including development of biosimilars and innovative fast-acting insulin analogs.

Global Market Segmentation: Identifying Major Short-Acting Insulin Industry Segments

The short-acting insulin market covered in this report is segmented –
1) By Formulation: Regular Insulin, Rapid-Acting Insulin
2) By Dosage Form: Vials, Pre-filled Pens, Cartridges
3) By Route Of Administration: Subcutaneous, Intravenous
4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes
5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies Subsegments:
1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin
2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine

Pre-order the 2025 Short-Acting Insulin Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Short-Acting Insulin Market?

The key trends in the short-acting insulin market are:

• Advancements in insulin delivery devices and technologies are emerging trends in the market.
• Innovative fast-acting insulin analogs are shaping the future of the market.
• The development of biosimilars is a significant trend in the market.
• There's a shift towards patient-centric care, driving changes in the market.

Who Are the Top Competitors & Leading Players in the Short-Acting Insulin Market?

Major players in the short-acting insulin market are:

• Sanofi S.A.
• Eli Lilly and Company
• Novo Nordisk A/S
• Baxter International Inc.
• Eisai Co. Ltd.
• Sumitomo Pharma Co. Ltd.
• Biocon Limited
• Kissei Pharmaceutical Co. Ltd.
• Lupin Limited
• Wockhardt Ltd.
• Lannett Co. Inc.
• MannKind Corporation
• Sihuan Pharmaceutical Holdings Group Ltd.
• Julphar(Gulf Pharmaceutical Industries)
• Geropharm LLC
• Bioton S.A.
• hec pharm co. ltd
• ADOCIA SAS
• Gan & Lee Pharmaceuticals Co. Ltd.
• Adocia S.A.S.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the short-acting insulin market in 2024